BioLife Solutions, Inc. (BLFS) Stock
Fundamentals
Recent news

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BLFS

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
BLFS

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BLFS
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BLFS

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
BLFS

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
BLFS

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
BLFS

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
BLFS

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
BLFS

Repligen to buy cell therapy maker BioLife in $1.5 billion deal
Repligen to buy cell therapy maker BioLife in $1.5 billion deal
BLFS

BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
BLFS

4 Medical Product Stocks to Buy From a Challenging Industry
4 Medical Product Stocks to Buy From a Challenging Industry
BLFS
About BioLife Solutions, Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Roderick de Greef | CEO & Chairman | 1960 |
| Mr. Sean Werner Ph.D. | Chief Technology Officer | 1974 |
| Dr. Aby J. Mathew Ph.D. | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | 1972 |
| Mr. Todd Berard | Chief Commercial Officer | 1969 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
6 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0.7 | +24.8 | -29.4 | -0.6 | ||||||||
| 2022 | -20.0 | -22.6 | -4.1 | -46.4 | +4.1 | +3.4 | +31.6 | +22.4 | -4.1 | +6.1 | -11.8 | -16.8 |
| 2023 | +32.7 | -1.1 | -4.6 | -12.8 | +29.0 | -4.3 | -7.5 | -31.7 | +3.1 | -24.8 | +20.9 | +22.6 |
| 2024 | +6.4 | -6.0 | +3.2 | -2.0 | +22.9 | +0.8 | -0.3 | |||||
| 2026 | -1.6 | +9.3 | +17.5 | +6.0 | +9.8 | +15.3 | +8.5 |



